Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kamran Shayesteh

Plastic and Reconstructive Surgery Johnstown, PA Doctor of Osteopathy

NPI 1336150564 CMS profile 242206

1 Tech Park Dr Ste 1200, Johnstown, PA 15901

Open in the dashboard

General payments

$47,392

99 records reported · program years 2019–2025

Research payments

$1,000

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kamran Shayesteh of Johnstown, PA is reported in the CMS Open Payments database as having received $47,392 across 99 general payments and $1,000 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $12,209 17
2025 Research $1,000 1
2024 General $14,807 19
2023 General $17,248 20
2022 General $2,068 19
2021 General $540 10
2020 General $307 8
2019 General $213 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kamran Shayesteh
  • Plastic and Reconstructive Surgery median
  • Middle half of Plastic and Reconstructive Surgery
  • National median

In program year 2025, general payments to Kamran Shayesteh were reported at $12,209. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.

Show as a table
Year Kamran Shayesteh Plastic and Reconstructive Surgery median Middle half National median
2019 $213 $335 $121–$1,264 $163
2020 $307 $162 $57–$417 $114
2021 $540 $245 $89–$735 $132
2022 $2,068 $325 $120–$932 $149
2023 $17,248 $343 $129–$999 $160
2024 $14,807 $390 $141–$1,085 $164
2025 $12,209 $442 $150–$1,242 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Kerecis Limited $44,197 35 payments
  2. Musculoskeletal Transplant Foundation Inc. $1,414 12 payments
  3. Integra LifeSciences Corporation $618 17 payments
  4. DePuy Synthes Sales Inc. $246 7 payments
  5. Ethicon US, LLC $217 2 payments
  6. AstraZeneca Pharmaceuticals LP $125 1 payment
  7. Smith+Nephew, Inc. $110 6 payments
  8. Medical Device Business Services, Inc. $95 1 payment
  9. Mentor Worldwide LLC $67 4 payments
  10. W. L. Gore & Associates, Inc. $58 2 payments
  11. Other $244 12 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for serving as faculty or as a speaker for a medical education program $29,113 4 payments
  2. Travel and Lodging $6,423 16 payments
  3. Education $5,025 5 payments
  4. Food and Beverage $4,107 69 payments
  5. Consulting Fee $1,275 3 payments
  6. Honoraria $1,000 1 payment
  7. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $450 1 payment
Products named General payments · program years 2019–2025
  1. Kerecis Omega3 SurgiClose Wound Care $32,144 23 payments
  2. Kerecis Omega3 GraftGuide $17,968 15 payments
  3. Kerecis Omega3 SurgiClose Wound Care $17,003 12 payments
  4. Kerecis Omega3 SurgiClose Wound Care $17,003 12 payments
  5. Kerecis Omega3 Marigen Wound Care $17,003 12 payments
  6. Kerecis Omega3 Marigen Wound Care $15,141 11 payments
  7. Kerecis Omega3 Marigen Wound Care $14,177 8 payments
  8. Kerecis Omega3 Marigen Wound Care $14,177 8 payments
  9. Kerecis Omega3 Marigen Wound Care $14,177 8 payments
  10. Kerecis SurgiClose $12,031 11 payments
  11. Other $52,764 129 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Kerecis Limited $1,000 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

81

Median for Plastic and Reconstructive Surgery: 61

Drug cost

$2,795

Median for Plastic and Reconstructive Surgery: $369

Branded share of claims

25.9%

Median for Plastic and Reconstructive Surgery: 30%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Fluorouracil Generic 45 $2,677
Cephalexin Generic 15 $66
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 21 $52

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,638 Part D prescribers listed as Plastic and Reconstructive Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 74 billing codes

Paid by Medicare

$44,544

Medicare's payments for the services billed

Medicare patients

166

Average age 73

Services billed

447

86 women, 80 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 54%
Ischemic heart disease 36%
Diabetes 31%
Depression 31%
Chronic kidney disease 29%
Heart failure 20%
Atrial fibrillation 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

100 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic and Reconstructive Surgery in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record